6-K 1 tm2332190d1_6k.htm FORM 6-K

 

 

  

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

For the month of December 2023

 

Commission file number: 001-32749

 

FRESENIUS MEDICAL CARE AG

(Translation of registrant's name into English)

 

Else-Kröner Strasse 1

61346 Bad Homburg

Germany

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x                    Form 40-F ¨

 

 

  

 

 

 

 

EXHIBITS

 

The following exhibits are being furnished with this Report:

 

Exhibit 99.1 Convenience translation of a notification of impending merger pursuant to section 62 (3) sentence 2 of the German Transformation Act issued on December 7, 2023.
   
Exhibit 99.2 Convenience translation of a notification by Management Board on the composition of the Supervisory Board of Fresenius Medical Care AG pursuant to Section 197 sentence 3 UmwG in conjunction with Sections 31 para. 3, 97 AktG.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

DATE: December 7, 2023

 

  Fresenius Medical Care AG

  

  By: /s/ Helen Giza
  Name: Helen Giza
  Title: Chief Executive Officer and Chair of the Management Board

 

  By: /s/ Martin Fischer
  Name: Martin Fischer
  Title: Chief Financial Officer and member of the Management Board